DGKI and melanoma: To determine whether DGKi enhances suboptimal TCR signaling in effector CD8 T cells, we used both B16 melanoma cells and the pancreatic cancer cell line 6694c2 transduced to express low amounts of Tyrp1 (C2VTrp1) (Fig. 2A).